These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23376217)

  • 1. Characterization of the mouse promoter region of the acyl-CoA synthetase 4 gene: role of Sp1 and CREB.
    Orlando U; Cooke M; Cornejo Maciel F; Papadopoulos V; Podestá EJ; Maloberti P
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):15-26. PubMed ID: 23376217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
    Belkaid A; Ouellette RJ; Surette ME
    Carcinogenesis; 2017 Apr; 38(4):402-410. PubMed ID: 28334272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells.
    Dattilo MA; Benzo Y; Herrera LM; Prada JG; Castillo AF; Orlando UD; Podesta EJ; Maloberti PM
    Sci Rep; 2019 Jul; 9(1):10324. PubMed ID: 31311992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
    Kuwata H; Hara S
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
    Castillo AF; Orlando UD; Maloberti PM; Prada JG; Dattilo MA; Solano AR; Bigi MM; Ríos Medrano MA; Torres MT; Indo S; Caroca G; Contreras HR; Marelli BE; Salinas FJ; Salvetti NR; Ortega HH; Lorenzano Menna P; Szajnman S; Gomez DE; Rodríguez JB; Podesta EJ
    Cell Mol Life Sci; 2021 Mar; 78(6):2893-2910. PubMed ID: 33068124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.
    Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ
    J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
    Feng J; Lu PZ; Zhu GZ; Hooi SC; Wu Y; Huang XW; Dai HQ; Chen PH; Li ZJ; Su WJ; Han CY; Ye XP; Peng T; Zhou J; Lu GD
    Acta Pharmacol Sin; 2021 Jan; 42(1):160-170. PubMed ID: 32541921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases.
    Tang Y; Zhou J; Hooi SC; Jiang YM; Lu GD
    Oncol Lett; 2018 Aug; 16(2):1390-1396. PubMed ID: 30008815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
    Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation.
    Kan CF; Singh AB; Stafforini DM; Azhar S; Liu J
    J Lipid Res; 2014 Aug; 55(8):1657-67. PubMed ID: 24879802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
    Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
    Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
    Doll S; Proneth B; Tyurina YY; Panzilius E; Kobayashi S; Ingold I; Irmler M; Beckers J; Aichler M; Walch A; Prokisch H; Trümbach D; Mao G; Qu F; Bayir H; Füllekrug J; Scheel CH; Wurst W; Schick JA; Kagan VE; Angeli JP; Conrad M
    Nat Chem Biol; 2017 Jan; 13(1):91-98. PubMed ID: 27842070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
    Cui M; Xiao Z; Sun B; Wang Y; Zheng M; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Mar; 445(3):651-5. PubMed ID: 24576478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
    Kan CF; Singh AB; Dong B; Shende VR; Liu J
    Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cell contacts prevent t-BuOOH-triggered ferroptosis and cellular damage in vitro by regulation of intracellular calcium.
    Faust D; Wenz C; Holm S; Harms G; Greffrath W; Dietrich C
    Arch Toxicol; 2024 Sep; 98(9):2953-2969. PubMed ID: 38814333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma.
    Li X; Meng F; Wang H; Sun L; Chang S; Li G; Chen F
    Front Endocrinol (Lausanne); 2023; 14():1319969. PubMed ID: 38274225
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.